Navigation Links
FDA Approves Strativa Pharmaceuticals' Zuplenz® (ondansetron) Oral Soluble Film
Date:7/2/2010

WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ -- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.  Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.

The FDA approval was granted based on clinical study data comparing the bioequivalence of Zuplenz 8 mg to Zofran ODT® (orally dissolving tablet) 8 mg.  The pharmacokinetic results of these studies demonstrated that a single dose of Zuplenz, taken with or without water and under fed and fasting conditions, was comparable to Zofran ODT.

"The FDA approval of Zuplenz marks an important milestone for Strativa as it reinforces our commitment to enhancing prescription products to meet the different needs of patients," said John A. MacPhee, President, Strativa Pharmaceuticals. "Zuplenz offers an innovative and convenient, easy-to-take formulation for patients who have trouble swallowing tablets, while providing the trusted efficacy expected from ondansetron."

Zuplenz uses proprietary PharmFilm® oral soluble film technology from MonoSol Rx to rapidly dissolve on the tongue without the need for water, which can cause additional discomfort for some patients suffering from nausea and vomiting.  Zuplenz will be offered in 4 mg and 8 mg dosage strengths, and is expected to be available in retail pharmacies in the third quarter of 2010.

Nausea and vomiting is a common side effect associated with chemotherapy, radiotherapy, and surgery. Left untreated, nausea and
'/>"/>

SOURCE Strativa Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Harwood Feffer LLP ( www.hfesq.com ... directors of PDL BioPharma, Inc. ("PDL" or the "Company") ... has breached its fiduciary duties to shareholders or violated ... 2014, the Company disclosed: "On September 11, 2014, [PDL] ... Ernst & Young LLP ("EY"), that it was resigning ...
(Date:9/19/2014)... Pa. , Sept. 19, 2014  Today ... two new variable angle plating systems featuring its ... surgeons can adapt screw trajectory to match patient ... specific fragments of bone. The systems are being ... & Ankle Society (AOFAS) and the International Federation ...
(Date:9/19/2014)... , Sept. 19, 2014 The Parenteral Drug ... harmonize global post-approval changes protocols. The ... the topic expressed by industry participants and regulatory authority ... this month in Washington, DC . ... on hand for the workshop. Attendees indicated openness to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2
... Diagnostics, an FDA licensed and ISO certified biomedical ... CulGenex™, a new brand of culture media, biological ... purification kits, and transfection reagents for molecular biology ... Crowe (molecular biologist from the University of Pittsburgh) ...
... Kan., Sept. 16 ScriptPro has been awarded a ... National Institutes of Health (NIH) in ... and drug information systems will be implemented in the ... control and identification of drugs and enhance the safety ...
Cached Medicine Technology:CulGenex™ by Hardy Diagnostics Assists Medical Researchers! 2National Institutes of Health Chooses ScriptPro for Pharmacy Automation 2
(Date:9/20/2014)... the popular online supplier of wedding dresses and special ... collection of cocktail gowns. This afternoon, the company announced ... outfits; it intends to expand its online market in ... cocktail dresses in the company’s online store. ... experience in the industry of women’s special occasion dresses. ...
(Date:9/20/2014)... Recently, UWDress.com, an innovative company that ... occasion outfits, has launched a special offer for its ... are popular among worldwide clients. Now, all the company’s ... dresses on its website. , Additionally, the firm ... the world. Great custom made items can be ordered ...
(Date:9/20/2014)... September 20, 2014 Final Cut Pro ... the release of the Information theme for FCPX filmmakers. , ... to describe the Information theme,” says Christina Austin, CEO of ... look so professional.” , Information features easy to use controls ... of the environment. Change the background color, color of each ...
(Date:9/20/2014)... September 20, 2014 The children of ... balanced and active play they need. An empty lot ... - Lakeview Campus was transformed into a kid-designed playspace ... 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), ... KaBOOM! believes a playground is more than a playground. ...
(Date:9/19/2014)... 19, 2014 Unbound , an international ... in regions of the Philippines being affected by both a ... 1,060 families evacuated to the nearest public schools while others ... rain and gusty winds to portions of the northern Philippines. ... Some homes filled with more than 10 feet of water. ...
Breaking Medicine News(10 mins):Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2
... Gist, D.D.S., who practices general dentistry in Flint, Mich., was ... during a meeting of the ADA House of Delegates ... ADA presidency in October 2010 and will lead the more ... Dr. Gist will be the ADA,s first African-American president. , ...
... , - Significant variation exists in the quality of ... disease in U.S. hospitals. , - Hospitals receiving performance ... Guidelines (GWTG) quality improvement program appear to have better ... DALLAS, Oct. 6 Hospitals receiving performance awards from ...
... Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner ... largest exporter by volume in the medical dressing industry ... to list its common stock on NYSE Amex. , ... on Thursday, October 8, 2009, until which time its ...
... prevention or delay of full-blown disease seen in treated ... Among patients who show early signs of multiple sclerosis, ... halve the risk that they will develop full-blown disease, ... who are diagnosed with multiple sclerosis first show signs ...
... a leading brand in the weight management industry, launched Metabolife ... about positive, incremental changes to their lives and the lives ... with the launch of www.joinlessismore.com . , ... changes that delivers lasting results and weight loss is just ...
... West Bloomfield Hospital is embarking on a research study for ... , The clinical trial will test whether gene transfer ... who have lost responsiveness to drug therapy. , ... Parkinson,s disease patient population that has had a long-standing need ...
Cached Medicine News:Health News:Michigan Dentist Chosen President-Elect of the American Dental Association 2Health News:American Heart Association Quality News: Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 2Health News:American Heart Association Quality News: Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 3Health News:Winner Medical to Begin Trading on NYSE Amex on October 8, 2009 2Health News:Winner Medical to Begin Trading on NYSE Amex on October 8, 2009 3Health News:Early Drug Treatment May Cut Multiple Sclerosis Risk 2Health News:Communities Nationwide Learn 'Less Is More' from Metabolife(R) Through 1,000 In-Home Parties and An Interactive Site www.joinlessismore.com 2Health News:Communities Nationwide Learn 'Less Is More' from Metabolife(R) Through 1,000 In-Home Parties and An Interactive Site www.joinlessismore.com 3Health News:Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinson's Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: